Introduction
Polycomb group (PcG) proteins are an important group of epigenetic regulators that repress gene expression by modifying chromatin structure (Mills, 2010; Simon and Kingston, 2009 ). PcG proteins function as two complexes. The PRC2 protein complex includes four core proteins -Ezh2, Suz12, eed, and RBAP48. The catalytic subunit is Ezh2, a methyltransferase that trimethylates lysine 27 of histone H3 (H3K27) (Simon and Kingston, 2009 ). The complex contains three non-catalytic subunits, including Suz12, eed (embryonic ectoderm development) and RBAP48 (retinoblastoma-binding protein p48).
Suz12 and eed are required for optimal Ezh2 histone methyltransferase activity. Interaction of Suz12 and eed with Ezh2 results in a 1000-fold increase in Ezh2 catalytic activity, showing that the full complex is required for optimal H3K27me3 formation (Pasini et al., 2004) . The core of the PRC1 protein complex includes Ring1B, Bmi-1, PH1 and CBX (Simon and Kingston, 2009 ). The catalytic subunit, Ring1B, ubiquitinylates H2A-K119 and is optimally active in association with Bmi-1 (Li et al., 2006 ). An important role of the CBX protein is interaction with H3K27me3 to anchor the PRC1 complex to chromatin (Eckert et al., 2011) . PRC1 has ubiquitinylates H2A-K119 as part of the process leading to a closed chromatin state.
PcG protein expression is altered in cancer cells and tumors and this is linked to increased cancer cell proliferation and survival (Eckert et al., 2011; Mills, 2010) . For example, Bmi-1 level is increased in a host of cancer cell types (Mills, 2010) and can cooperate with myc to promote B-and T-cell lymphoma formation (Jacobs et al., 1999) . Elevated Bmi-1 expression is associated with repression of the cyclin dependent kinase inhibitors p16 ink4a and p19 arf in several systems (Jacobs et al., 1999) . Elevated Ezh2 expression is associated with poor prognosis and aggressive tumor metastasis (Kleer et al., 2003) .
Interfering with Ezh2 expression retards cell proliferation and induces cell cycle arrest at the G2/M transition in the primary human fibroblasts (Tang et al., 2004) . Conversely, overexpression of Ezh2 shortens G1 and causes cell accumulation in S phase in cultured mouse embryonic fibroblasts (Bracken et al., 2003) .
Epidemiological studies indicate that consumption of cruciferous vegetables may reduce epithelial
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This article has not been copyedited and formatted. The final version may differ from this version. cancer (van Poppel et al., 1999) . Sulforaphane (SFN, 1-isothiocyanato-4-(methylsulfinyl) butane) is an abundant bioactive isothiocyanate found in broccoli and broccoli sprouts and it is an important candidate chemopreventive agent (Clarke et al., 2008) . It activates phase II detoxification enzymes such as glutathione-S-transferase and suppresses phase I carcinogen activation enzymes (Brooks et al., 2001) .
SFN suppresses cancer cell proliferation and inhibits cancer formation in carcinogen-induced, genetic and xenograft animal cancer models . SFN suppresses cancer cell survival via a number of mechanisms (Clarke et al., 2008) . Of particular interest in the present work are findings that SFN modulates epigenetic phenomena (Myzak et al., 2004) . Sulforaphane-dependent suppression of HDAC activity has also been reported in BPH-1, PC-3 and LNCaP prostate cancer cells . SFN has been shown to be effective in preventing skin cancer. For example, topical application of sulforaphane-containing broccoli sprout extract protects against UVB-induced skin carcinogenesis in SKH-1 mice (Dinkova-Kostova et al., 2006) . SFN is also inhibits 7,12-dimethylbenz(a)anthracene/12-Otetradecanoylphorbol-13-acetate-induced cancer in C57BL/6 mice . However, knowledge is limited regarding the molecular mechanisms of SFN action in inhibiting skin cancer formation. In the present study, we examine the role of PcG proteins as mediators of SFN regulation of skin cancer cell survival.
procaspase 9 (9502) and mouse anti-procaspase 8 (9746) were from Cell Signaling (Danvers, MA).
Mouse monoclonal anti-Suz12 (#04-046) and rabbit polyclonal anti-H3K27me3 (#07-449) were purchased from Upstate Biochemicals (Lake Placid, NY Rockville, MD). The cells are maintained in a DMEM medium containing 5% fetal calf serum, antibiotics, D-glucose, L-glutamine, and sodium pyruvate (Balasubramanian et al., 2010) . For cell proliferation assays, A431, HaCaT and SCC-13 cells were plated at low density in 9.5 cm 2 dishes and allowed to attach for 24 h. Cells were then treated with fresh medium containing 0.1% DMSO or indicated concentration of SFN. After 48 h the cells were harvested with 0.025% trypsin containing 1 mM EDTA, fixed in isotonic buffer and counted utilizing coulter counter. For cell cycle analysis, sub-confluent A431,
HaCaT and SCC-13 cells were treated with SFN (0 -20 μM) or vehicle for 24 h. The cells were then trypsinized, washed twice in cold phosphate-buffered saline (PBS) and centrifuged. The cell pellets were resuspended in PBS and fixed in cold methanol. The cells were then washed and suspended in PBS, incubated with RNAse and stained with propidium iodide prior to flow cytometric analysis.
Bmi-1 adenovirus infection
Construction of human Bmi-1 encoding adenovirus (tAd5-hBmi-1), empty virus (tAd5-EV), and the helper TA virus (Ad5-TA) are described elsewhere (Lee et al., 2008) .
SCC-13 cells were plated into 35 mm dishes at 20% confluence and allowed to attach. After 24 h the
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This article has not been copyedited and formatted. The final version may differ from this version. formation SFN has been reported to suppress cancer cell survival in a number of systems (Singh et al., 2004a; Singh et al., 2004b; . We began by examining the impact of SFN treatment on SCC-13 cell proliferation. SFN treatment suppresses SCC-13 cell number in a concentration-dependent manner and treatment with intermediate levels of SFN (10 μM) maintains cell number at the initial plating density (Fig. 1A) . Since increased PcG protein expression is known to be associated with increased skin cancer cell survival (Balasubramanian et al., 2010) , we determined whether SFN treatment is associated with reduced PcG expression. Fig. 1B shows that the reduction in cell number is associated with a parallel reduction in Suz12, Ezh2 and Bmi-1 level. The end-product of Ezh2 action is H3K27me3 formation (Pasini et al., 2004) and our studies confirm a reduction H3K27me3 level with the reduction in Ezh2 expression (Fig. 1B) . Time course studies indicates that the suppression is complete within 24 h after additional of 20 μM SFN (Fig. 1C ).
SFN modulates cell cycle
We next assessed the impact of SFN on cell cycle progression and apoptosis. SFN treatment causes PC-3 prostate cancer cells to arrest in G2/M, (Singh et al., 2004b) while G1/S arrest is observed in DU145 and LNCaP cells (Wang et al., 2004) . SFN-induced G2/M cell cycle arrest has been reported to involve increased expression of p21 Cip1 and altered expression of cyclin B1, cdc25b and cdc25c in different cancer cells (Singh et al., 2004b; Herman-Antosiewicz et al., 2007; Gamet-Payrastre et al., 2000) . Fig. 2A shows that SFN treatment of SCC-13 cells increases the number of G2/M events from 11% to 34% and is associated with a concomitant decrease in G1 events from 48% to 25%. In contrast, the number of S-phase cells is not altered. Fig. 2B shows that this arrest is associated with a reduction in cdk1, cdk2, cyclin A and cyclin B1. The level of cdc25c, the phosphatase that dephosphorylates and activates cdk1 (Donzelli and Draetta, 2003) , is also reduced. In contrast, p21 Cip1 level is increased (Fig. 2B ). These findings are consistent with cessation of cell and 9, and an increase in PARP cleavage. The SFN impact is similar to that observed for the bioactive green tea polyphenol, (-)-epigallocatechin-3-gallate, in that it alters cell cycle regulatory protein expression to reduce cell proliferation and increases apoptosis (Balasubramanian et al., 2010) .
However, SFN alters the relative distribution of cells within the cell cycle, while EGCG does not (Balasubramanian et al., 2010) . Considering the strong caspase and PARP cleavage observed in 20 μM SFN treated cells, cell cycle analysis shows only a modest increase in subG1 events (Fig 2A) . However, the subG1 fraction is markedly increased when cells are treated for longer periods or with increased levels of SFN. Treatment with 40 μM SFN for 24 h, for example, increases G1 content to 55%, reduces G2 content to 28% and increases subG1 events to 11% (not shown). Fig. 1 consistent with reduced proliferation. SFN also activates procaspase 3 and PARP cleavage. However, these changes are partially reversed in the presence of Bmi-1 (Fig 3C) . These findings suggest that the SFN-dependent protein reduction is due to direct effects on protein level and not mRNA level. The proteasome has been reported to be involved in PcG turnover in selected cell types (Tan et al., 2007; Dimri et al., 2010) . To assess this possibility, we treated SCC-13 cells with SFN in the presence or absence of lactacystin and monitored the impact on Bmi-1, Ezh2 and H3K27me3
Impact of Bmi-1 on SFN-dependent events The experiments in
SFN increases proteasome-dependent PcG protein degradation
formation. Fig. 5A shows that lactacystin inhibits the SFN-dependent loss of these markers. To provide additional evidence for proteasome involvement we treated cells with SFN for 0 -24 h and monitored for the presence of ubiquitinated Ezh2 and Bmi-1. Immunoblot of the immunoprecipitates with anti-ubiquitin reveals evidence for specific ubiquitination of Bmi-1 and Ezh2 (Fig. 5C) .
No ubiquitination was observed in the IgG immunoprecipitated group. The onset of increased ubiquitination was at 8 h post-application of SFN.
SFN regulation of PcG protein level in A431 and HaCaT cells To assess whether proteasome
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This article has not been copyedited and formatted. The final version may differ from this version. regulation of PcG proteins is generally observed, we examined the impact of sulforaphane on Ezh2, Bmi-1 and H3K27me3 formation in A431 and HaCaT cells. We first examined the impact of SFN on cell survival to determine whether SFN reduces cell number in these cells. Fig. 6A shows that A431 and
HaCaT cells display dose-dependent decrease in cell survival and that this reduction is associated with decreased expression of Bmi-1 and Ezh2, and reduced H3K27me3 formation (Fig. 6B) . We anticipated that these changes may also be due to proteasome-dependent degradation. We therefore treated cells with SFN in the presence or absence of lactacystin. As shown in Fig. 6C , lactacystin inhibits the SFNdependent reduction in Bmi-1 and Ezh2 level. These results confirm that SFN-dependent suppression of PcG level is proteasome dependent in these cell lines. mutations. SFN treatment of A431 cells increases G2/M events from 7% to 24% with a parallel reduction in G1 events (Fig. 7A) . In HaCaT cells, SFN increases G2/M events from 15% to 51% with a concomitant decrease in G1 and S phase (Fig.7A ). These changes are associated with increased p21 Cip1 and a marked reduction in cdc25c (Fig. 7B ). In contrast, cdk1 level is not regulated and cyclin B1 level is increased. We also examined the impact of SFN on apoptosis indicators, since sub-G1 events are increased in SFN-treated A431 and HaCaT cells (Fig. 7A/B) . As shown in Fig. 7C , we observe reduced levels of procaspase-3, 8 and 9 and also increased PARP cleavage in SFN-treated A431 and
SFN regulation of cell cycle and apoptosis in A431 and
HaCaT cells.
SFN impact on H3K27me3 demethylases
Jumonji domain protein 3 (JMJD3) and ubiquitously transcribed tetratricopeptide repeat, X protein (UTX) are histone demethylases that oppose PcG protein action and demethylate H3K27me3 (Agger et al., 2007; Agger et al., 2009; Barradas et al., 2009 ). We therefore examined the possibility that the change in H3K27me3 level may, in part, result from a change in expression level of these demethylases. SCC-13, A431 and HaCaT cells were treated for 24 h with 20
μM SFN prior to assessment of JMJD3 and UTX level. increase in H3K27me3. Since the reverse is observed, it appears likely that the decrease we observe is due to loss of Ezh2.
Discussion
Sulforaphane is an important candidate dietary cancer preventive agent (Clarke et al., 2008) .
However, the mechanism of action is not fully elucidated and the impact of SFN treatment on PcG protein function in skin cancer has not been studied. Our data indicate that SFN suppresses proliferation of epidermis-derived skin cancer cell lines, including SCC-13 and A431. In addition, SFN treatment suppresses proliferation of HaCaT cells, an immortalized but non-tumorigenic epidermis-derived cell line.
To understand the mechanism by which SFN suppresses proliferation, we examined the impact of SFN on cell cycle control proteins. Flow cytometry analysis reveals cell cycle arrest in G2/M and an associated reduction in cyclin B1, cdc25c and cdk1 level. Based on the reduction in these cell cycle regulatory proteins, we anticipate that SFN treatment causes reduced cdk1/cyclin B1 and cdk2/cyclin A complex formation. This, in conjunction with accumulation of p21 Cip1 , the cell cycle kinase inhibitor, would be expected to induce cell cycle arrest. These results are consistent with previous reports in prostate cancer. For example, Singh and colleagues described SFN induced G2/M arrest in PC-3 cells as associated with a marked decrease in cyclin B1, cdc25B and cdc25c level, and accumulation of Tyr-15-phosphorylated (inactive) cdk1 (Singh et al., 2004b) . We also noticed a marked decrease in the level of cdk2 and cyclin A, although we did not observe a change in the percentage of cells at S phase of the cell cycle.
Additional studies reveal that SFN-treatment induces apoptosis as evidenced by increased subG1 Recent studies suggest that PcG proteins play an important role in enhancing epithelial cancer cell proliferation and survival (Balasubramanian et al., 2010; Lee et al., 2008) . Elevated Bmi-1 expression is observed in prostate, lung, breast, ovarian and skin cancer (Glinsky et al., 2005; Lee et al., 2008) and Ezh2 is amplified and overexpressed in prostate, pancreas, breast and ovarian cancer (Kleer et al., 2003; Liu et al., 1992) . Overexpression of Ezh2 is linked with the invasion and progression of malignant tumors, especially in prostate cancer (Liu et al., 1992) , and knockdown of Ezh2 or Bmi-1 inhibits cancer cell growth, motility, invasion and tumor-forming ability Xu et al., 2011) . We have demonstrated that Bmi-1, Ezh2 and H3K27me3 are elevated in skin cancer cells and tumors (Lee et al., 2008) .
In the present study, we show that SFN treatment suppresses Bmi-1 and Ezh2 levels, and that the loss of Ezh2 does not influence histone H3 level, but is associated with reduced H3K27me3 formation.
These changes are observed as early as 8 to 16 h after initiation of treatment with 15 -20 μM SFN.
Moreover, SFN treatment reduces JMJD3 and UTX level, which would lead to increased H3K27me3 formation. JMJD3 and UTX are demethylases that remove the trimethyl mark from H3K27 (Agger et al., 2007; Agger et al., 2009; Barradas et al., 2009) . Taken together, these findings suggest that the major reason for reduced H3K27 level is loss of Ezh2. Basal PcG expression in tumors is controlled by a host of mechanisms including regulation of transcription and control of mRNA level and mRNA translation rate. Of particular interest are recent findings suggesting microRNA control of Ezh2 expression (Alajez et al., 2010; Smits et al., 2010) . miR-101 level is reduced in glioblastoma and this is associated with increased Ezh2 expression and increased cancer cell survival and migration (Smits et al., 2010) .
Several microRNAs, including miR-26a, miR-101 and miR-98, suppress Ezh2 level, and loss of miR-98 expression is associated with increased Ezh2 expression in recurring tumors of nasopharyngeal
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This article has not been copyedited and formatted. The final version may differ from this version. carcinoma (Alajez et al., 2010) . miR-138 has also suppresses Ezh2 level (Kisliouk et al., 2011) . In most cases, it is not known whether these miRNA species control Ezh2 level by reducing mRNA stability or inhibiting protein translation (Cannell et al., 2008) . Because of the possibility that miRNA may be important in mediating SFN action, we examined the impact of SFN treatment on Ezh2 and Bmi-1 mRNA level and found that the level of mRNA encoding these proteins is not reduced by SFN treatment. This suggests that reduced mRNA level, whether associated with miRNA-mediated or transcriptional mechanism, is not the basis for the SFN-dependent reduction in Ezh2 or Bmi-1 level.
Given that the loss of PcG protein expression does not involve reduced mRNA level, we looked to mechanisms that control protein stability and in particular the potential role of the proteasome. Recent studies highlight a role for the proteasome in regulating PcG protein level (Tan et al., 2007; Dimri et al., 2010) . 3-deazaneplanocin A (DZNep), an s-adenosylhomocysteine hydrolase inhibitor, reduces Ezh2
and Suz12 level in MCF-7 cells and this response is partially inhibited by proteasome inhibitors (Tan et al., 2007) . In addition, omega-3 polyunsaturated fatty acids increase proteasome-dependent degradation of Ezh2 in MDA-MB-231 breast cancer cells (Dimri et al., 2010) . Our studies are consistent with a role for the proteasome in SFN-dependent reduction of PcG protein level in skin cancer cells. protein components. Kensler and colleagues showed that SFN treatment increases PSMB5 level in murine embryonic fibroblasts (Kwak et al., 2003) . PSMB5 is a key protein component of the 20S
proteasome and in this system SFN triggers Nrf2 transcription factor interaction with the PSMB5 gene promoter to drive increased PSMB5 expression (Kwak et al., 2003) . This is consistent with a report showing that SFN prevention of skin cancer is in part mediated by Nrf2 , as Nrf2 knockout mice are more susceptible to DMBA/TPA skin tumor development. Thus, it is possible that the increase in proteasome activity in SCC-13 cells may be due, in part, to a SFN-induced increase proteasome subunit gene expression.
A recent study documents increased PcG protein expression in SCC-13 cells and shows that (-)-epigallocatechin-3-gallate (EGCG), a bioactive green tea polyphenol, reduces this expression (Balasubramanian et al., 2010) . Moreover, vector-mediated maintenance of Bmi-1 expression in EGCGtreated cells restores cell number and expression of pro-proliferation cell cycle markers, and suppresses EGCG-stimulated pro-apoptotic events (Balasubramanian et al., 2010) . Our present studies describe a similar response in that the SFN-dependent reduction in cell number, PcG protein expression, H3K27me3 formation, and apoptotic marker activation is partially reversed by forced maintenance of Bmi-1 expression. Such an impact of Bmi-1 has been reported in other systems. For example, ectopic expression of Bmi-1 renders glioma cells resistant to doxorubicin-and UV irradiation induced cell death, whereas knockdown of endogenous Bmi-1 accelerates cell death (Li et al., 2010) . Although Bmi-1 antagonism of cell death is an emerging theme, the downstream targets of Bmi-1 that drive enhanced survival vary among cell types. For example, Bmi-1 suppresses Ink4a/Arf expression leading to enhanced cell survival in lymphoid cells (Jacobs et al., 1999) . While a host of cell cycle proteins are PcG targets in skin cancer cells (Balasubramanian et al., 2010) , signaling cascades are also important targets (Li et al., 2010) .
In summary, our studies examine the impact of SFN on PcG protein expression in a skin cancer system. We show that the SFN-dependent reduction in PcG protein level is mediated via the proteasome. We also show that the impact of SFN treatment can be attenuated when Bmi-1 levels are
This article has not been copyedited and formatted. The final version may differ from this version. prepared and equivalent amounts of protein were electrophoresed on a 6-10% denaturing polyacrylamide gel and transferred onto a nitrocellulose membrane. JMJD3, UTX, and β -actin levels were monitored using specific antibodies. Similar results were observed in each of three experiments.
